Syndol returns

Sanofi has announced the return of the original formulation Syndol Tablets for short-term tension headache and migraine relief after five years of absence. Rolling out in the UK from the end of February 2019 and available over-the-counter in pharmacies, the tablets contain doxylamine succinate– a first-generation antihistamine – as well as paracetamol, codeine phosphate and caffeine. The product provides short-term relief of acute moderate pain when paracetamol, aspirin or ibuprofen alone are not enough, Sanofi explains. Due to the codeine content, Syndol can cause addiction and should be used for three consecutive days only.

Ceuta Healthcare: 0844 243 6661

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Training Matters's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.